text:
Adams Golf Speedline Plus Complete Set - (Graphite/Steel)
Product Information:
Gear up with everything you need for a day on the course with the Speedline Plus Complete Set. Equipped with everything from the driver to the putter, this set features clubs with aerodynamically shaped heads for improved performance. Each club is designed to optimize key components of a golf game, including swing speed and trajectory. The Tom Watson RC14 Sand Wedge puts the finishing touch on the Adams Golf® Speedline Plus Complete Set.
Click here for additional information relating to the Manufacturer's Warranty.
What's Included (Regular Flex):
3 & 5 Woods
4 & 5 Hybrids
6-9 Irons
Pitching Wedge
Sand Wedge
Durable Golf Bag
Headcovers (5)
What's Included (Senior Flex):
3 & 5 Woods
5 Hybrid
6-9 Irons
Pitching Wedge
Sand Wedge
Durable Golf Bag
Headcovers (4)
Driver SPECS:
3 Wood SPECS:
5 Wood SPECS:
4 Hybrid SPECS:
5 Hybrid SPECS:
6 Iron SPECS:
7 Iron SPECS:
8 Iron SPECS:
9 Iron SPECS:
Putter SPECS:
- Available in standard length and 1" long length shaft options
- Regular Flex Complete Set includes 12 pieces; Senior Flex Complete Set includes 11 pieces
- Aerodynamically shaped heads provide faster club head speeds with any club in the bag
- Driver features high Moment of Inertia for more stability at impact and greater accuracy
- Fairway woods feature an advanced slot design and enlarged sweet spot for increased playability
- Hybrids feature an ultra-thin crown and lower Center of Gravity for ideal launch conditions
- Irons and wedges feature a low Center of Gravity gets the ball airborne quickly for playability
- Tom Watson RC14 Sand Wedge for improved shot shaping, feel, and versatility near the green
- Classic shaped putter constructed of soft stainless steel for enhanced feel and style
- Metalwood headcovers and a lightweight bag for club transportation and protection
- Adams Golf
Click here for additional information relating to the Manufacturer's Warranty.
What's Included (Regular Flex):
What's Included (Senior Flex):
Driver SPECS:
- Loft: 11°
- Lie: 57°
- Length: 45.5"
- Swing Weight: D2
3 Wood SPECS:
- Loft: 15°
- Lie: 58°
- Length: 43"
- Swing Weight: D1
5 Wood SPECS:
- Loft: 17°
- Lie: 59°
- Length: 59"
- Swing Weight: D1
4 Hybrid SPECS:
- Loft: 23°
- Lie: 60.5°
- Length: 39"
- Swing Weight: D1
5 Hybrid SPECS:
- Loft: 26°
- Lie: 61°
- Length: 38"
- Swing Weight: D1
6 Iron SPECS:
- Loft: 29°
- Lie: 61.5°
- Length: 37.5"
- Swing Weight: D1
7 Iron SPECS:
- Loft: 33°
- Lie: 62°
- Length: 37"
- Swing Weight: D1
8 Iron SPECS:
- Loft: 37°
- Lie: 62.5°
- Length: 36.5"
- Swing Weight: D1
9 Iron SPECS:
- Loft: 41°
- Lie: 63°
- Length: 36"
- Swing Weight: D1
- Loft: 45°
- Lie: 63.3°
- Length: 35.8"
- Swing Weight: D1
- Loft: 56°
- Lie: 63.5°
- Length: 35.3"
- Swing Weight: D3
Putter SPECS:
- Loft: 4°
- Lie: 70°
- Length: 35"
Country of Origin: ImportedWeb ID: 29755466
Customer Reviews:
Rated 4.2 out of 5�by 26 reviewers.
Rated 5 out of 5�by Jbrown72 Speedline Plus Purchased this set day after Christmas and hit the course the next day. I am a below average player and only started playing this year. These clubs considerably improved my game and gave me the confidence to continue with the sport. I had a really old set and am so glad I upgraded. The irons are very forgiving and the hybrids really send the ball a good distance.played a full 36 holes with no cosmetic or quality concerns with the clubs, great set I would definitely recommend them to anyone looking to upgrade on a budget. December 27, 2016
Rated 4 out of 5�by Josh1234 Speedline Plus Set This is a great set that is great for beginners ,and offers a lot of forgiveness October 25, 2016
Rated 5 out of 5�by Vince As advestised The product is a great way to build a golf set with a sturdy bag as well. All items arrived as advertised. October 24, 2016
Rated 3 out of 5�by BraxtonsPops Could have been better Only hit a couple buckets of balls with this set before trying on course. First round, hole 3, I went to take the head cover off of my driver and it snapped at the hosel. I hadn't hit but maybe a dozen or so with the driver at that time. No crazy swings or anything. Just plain snapped. I was able to replace the set at my local Dick's Sporting Goods store. Played another round and no breakages. I really like playing with the set. They feel really good when striking the ball. Very forgiving. Driver, Fairway woods, hybrids, irons, wedges, all feel great. The putter, however, I can not play with. It just doesn't feel right for me. Feels cheap. Not really the best putter for me. I went ahead and bought an upgraded putter that fits my putting style better. Other than that the set is great and I recommend it to anyone who wants a good first set that they can play with for a long time. October 4, 2016
Rated 2 out of 5�by JB I Have Been Happier Ordered the clubs once, first set came in without the driver. Dick's overnighted a new set to me, all pieces included. After hitting less than 10 balls with the driver, the driver head went flying off. (The club did not contact the ground, as the tee was still standing straight up in the ground). Second replacement requires supervisor approval, so it is not even guaranteed that I will be able to get a new driver. Needless to say I have been pretty disappointed with my experience so far. May 28, 2016
Rated 5 out of 5�by TheSparky Great first set I purchased these yesterday from my local Dick's in San Marcos, CA. Ricky was polite, honest and understood I needed good information in a hurry (1 hour to tee time!) After a quick and precise explanation of the options in my price range, I thanked him and bee-lined it for the Adams. Almost immediately, I was at the first tee with this set. Getting to know a new set of clubs can be tricky, but these make it easy to have zero buyer's remorse. From the first time I connected with the driver I knew this was the best set of clubs I could have bought around $500. The sweet spot is HUGE, which is just perfect for beginners looking to find more fulfillment in the game. The irons are amazingly forgiving, and the sand wedge is one of the nicer ones I've used (not that I ever need one). I used every club in the bag and believe the fairway hybrids in this set would impress all but the snootiest of golfers. It feels really good connecting with them and the accuracy of these things immediately upped my game. I'll make mention of the putter and the woods since I know you're curious. The putter is the club that's gonna take some time for me to figure out. The balance on it is pretty focused and maybe not as forgiving as the rest of the bag. Again, with time I'll get used to it's character and we'll get along. I didn't use the woods that much given the layout of the course I was playing at (The Fountains at Welks) but found them to be just as precise as the rest of the bag. Buy them and enjoy! They are well made clubs in a sturdy bag just bursting with quality. May 23, 2016
Rated 4 out of 5�by Jerry Adams Golf Clubs I recently purchased a set of Adam?s Speedline Plus golf clubs this past summer as my very first personal set of clubs and used them approximately 10-15 times since. I had previously been using a friends second set of clubs and knew that I wanted to get my own set. I have golfed the past two years roughly ten times a season and have had a bad slice with many of my shots. I knew I wanted to find a decent starter set to hone my skills, and then eventually purchase a new driver and putter. After reading numerous reviews and talking to avid golfers, I decided to purchase the Adam?s Speedline Plus set. This is a good product for beginners to purchase at a cheaper price than piecing together a set from multiple brands which can be expensive. I have seen improvements in my golf game since, due to the easy to hit nature of these clubs. My slice since purchasing these clubs has become non-existent The 4 and 5 Hybrid clubs are my favorite clubs to use on the fairway. I?ve never used hybrids before, but in my opinion they are the best clubs in the set. The irons are good in this set even though I have mainly used the eight iron and pitching wedge and haven?t had many issues with the other irons in the set. The putter is definitely a standard putter but I haven?t had any issues. Additionally if you like to walk the course, the strap on the bag is comfortable, and causes no pain. I have noticed some chipping of the paint on my hybrid clubs. It has just been minor chipping of paint and hasn?t affected the swing or contact with the ball. The other issue with this set of clubs is the bag that came with. The bag seems too small if you wanted to add any additional clubs. Additionally the bag does not hold much room for storage. Trying to find the right set of clubs to start golfing is tough because there are so many options to go with. Adam?s Speedline plus golf clubs are the set to definitely buy over any other brand. They are easy to swing, improve your distance, and are a steal for the price due to their quality. February 12, 2016
Rated 5 out of 5�by Rudy excellent clubs for the value I bought these clubs for my grandmother who retired in Arizona. She golfs approximately 3 times a week with my grandfather and some neighbors from the community. She has been consistently outscoring her group, including my grandfather who is not too happy, but he is a jerk anyway!!! I'm thinking of buying a set for my wife, who is new to golf. I just hope she doesn't kick my butt!!! January 31, 2016
Rated 5 out of 5�by Len Adams golf Clubs Did not use them yet, but seem very well made. For beginner golfer, these are great. January 31, 2016
Rated 2 out of 5�by avidgolffan311 everything but great I bought these as an extra set for when I travel. 2nd tee box and the head snapped straight off the shaft. I didn't hit the ground or anything. Now stuck with the 3 wood 4 holes later same result. Highly disappointed. April 26, 2015


text:
780 posts tagged with relationship by Anonymous.
Displaying 351 through 400 of 780.
We split up 20 years ago, can we do it again?
Work help: how to break this impasse? [more inside]
how to explain resume gaps
Well, that was dumb. I spent the past two summers spending time with my (now) ex-girlfriend. No jobs. No internships. How do I explain the resume gaps to employers/grad schools in the future? [more inside]
Break Up Decision Filter (including a long description)
Break Up Decision Filter (including a long description) [more inside]
Why did she tell me she was raped?
She told me she was raped. Why? [more inside]
How can I move from hook-up or "one night stand" to a real relationship?
How can I move from hook-up or "one night stand" to a real relationship? Is that possible? How would a "slut" get into a relationship? I am a 26 year old female who many might describe as promiscuous. I'm not embarrassed or ashamed of that, I'm having a lot of fun. But recently I now have a habit of sleeping with guys who I have a pretty big crush on, but the next morning they are always very "see you around!" If I invite them to hang out later they usually kindly decline. But honestly, I'd like to date them! I'd like to sleep with them again, and not just by accident because we happened to be at the same party. Is it possible to turn this sort of hook-up into more? Maybe nsfw inside. [more inside]
How to explain lack of relationship experience to a new love interest?
How to explain lack of relationship experience to a new love interest? [more inside]
Can we make this work?
I told myself I would never post a relationship question, but here goes: My boyfriend had, what amounts to in my mind, an emotional affair that's been going on for the past 6 months. I need help deciding if this is worth salvaging. There are, of course, lots of details inside. [more inside]
How to tell a date to tone down the cologne?
Help me find a nice/funny/not insane way to tell a guy I just started seeing that he's wearing too much cologne for me. Maybe I'm like this previous asker, but I find myself thinking things like, "ok, I'll sleep with him once and THEN tell him," which I know is kind of crazy. (Mostly because I'd rather not smell his cologne on my sheets for weeks after.) Is it ok to tell someone you just met that your lizard brain would like him a LOT better if he toned down the artificial scenting? I'm gay, if that matters, but any relevant experience or advice is welcome. Have you ever dealt with this situation successfully? [more inside]
The Case of the Ex
How do I separate my ex's rejection/betrayal from my post-coming out anxieties? [more inside]
I can't keep up with the happy-happy-joy-joy
Please give me some external validation that my supervisor's need for reassurance is really not ok, and advise on how to disguise my extreme discomfort. [more inside]
Reality check, please!
Mother in law invited herself on vacation, I'm not happy. Am I being unreasonable? [more inside]
Shut the door.
How to handle possible romantic interest from my boss? (Complication: I'm interested in him too but have no desire to wreck my career or relationship.) [more inside]
Help for a Very Late Bloomer
I am a guy who is inexperienced with relationships. I like a girl who has been my friend for couple of years. I don't know what her feelings are. We sometimes hang out together, but usually with other people. I want something more but don't know how to proceed. Details inside. [more inside]
Where's the sex drive?
My fiancé has almost not sex drive. Am I screwed? No pun intended. [more inside]
Boyfriend is scared to think about the future. Should I be patient or leave?
I'm in a new relationship that's going great, but he's scared of thinking about a future together, and we have different views on kids and marriage. Should I be patient, or is it better to cut my losses? [more inside]
My partner has developed agoraphobia, what do I do?
My SO is housebound by agoraphobia. What should I expect of his recovery? How can I help and how can I avoid hindering his recovery? And how can I best reduce any detrimental impact on my life and our relationship? Nice big snowflake enclosed. [more inside]
Is it okay to date a student once the semester is over?
Is it okay to date a student once the semester is over? [more inside]
How should healthcare professionals act when they (or their loved ones) are patients?
Health-care workers of MeFi: how do you act around doctors when you or a family member is receiving care? [more inside]
melodrama, fade-out, third option?
How do I dial back a friendship before my heart gets trampled any more? [more inside]
Is it possible to refurbish this mess into a more reasonable friendship? If so, how?
At baseline, I'm terrible with keeping in touch even with uncomplicatedly good friends. This situation is far from uncomplicated, though. [more inside]
Need help dealing with SO's depression
Need help dealing with my SO's job-related depression. [more inside]
Break up, yep.
Break-ups and the future: how to proceed? [more inside]
Can you marry, date other people, and stay sane?
Married and dating? [more inside]
How do I handle a divorce with geographical complications?
I'm seriously considering asking my wife for a divorce but need help figuring out how to deal with the logistics. [more inside]
healthy relationship unsupportive parents
I still want my parents' approval and support, but that's just not going to happen. How do you maintain your relationship with your unsupportive parents? [more inside]
Is it a crush or just being nice?
I think a friend of mine may have feelings for me, but I'm not sure how all that works nor what to do about it. Can you help a romantically clueless girl in the right direction? Details below. [more inside]
Dealing with GF's Relationship OCD
My girlfriend's OCD and anxiety causes her to get stuck in loops of obsessive thought that really mess with our relationship. How can I deal with this better, and can therapy help her? [more inside]
Non-Psycho Approach for New Relationship Issue
New relationship: Is it appropriate to ask who boyfriend is hanging out with and if so, how does one approach the topic without coming off as a psycho-control-freakazoid girlfriend? [more inside]
I screwed my new boss. Now I want to date him. Help?
One week into my new job, I slept with my boss. Now what? [more inside]
I Dread This Visit
How do I deal with a new boyfriend's new look? [more inside]
I don't know, he's just sort of faceless.
The person I'm going out with claims they have no sexual imagination, essentially. Can this be true? What can I do? [more inside]
How to repair a business relationship after a lawsuit?
How should I repair my relationship wth my former employer after a lawsuit? [more inside]
How do I rebuild trust and relationships with my family?
How can I rebuild my relationship with my SO and my parents when someone seems set to undermine it? [more inside]
Is her excessive temper a red flag for our wedding or can it be overcome?
I am months away from a wedding with deep reservations about my future wife's temperament, which often becomes physically violent. How do I persist? [more inside]
Friend sexually abused his girlfriends.
Found out a good friend sexually abused his girlfriends. Paralyzed. [more inside]
It isn't over, but it is.
I'm ending an awesome relationship because I'm moving to a different city for a much better job. How to make the best of our last few weeks together, and what's the "healthiest" level of contact to maintain? [more inside]
Forgive someone who stole from you?
Is it possible to forgive and go on loving someone who stole from you? (Long-winded story inside) [more inside]
Breaking up: yes, hard to do.
How can I do this break-up right? [more inside]
I lost my virginity and got herpes (maybe)
Yet another herpes post. There's been so many of these lately it's like an ominous sign. My boyfriend has genital herpes. I might have contracted it from him. I have already gone to a doctor and am awaiting test results. Help me/us prepare mentally and emotionally. [more inside]
Now or later?
Break up today or next week? [more inside]
Should I choose between my boyfriend or my career....2 years in advance?
Should I choose between my boyfriend or my career....2 years in advance? [more inside]
Tough decisions regarding my dog
I adopted a dog a few years ago and now I'm considering the possibility of giving her up. I feel awful about it and I'm not sure what to do. Good reason for doing it: starting med school. Not sure if it's a good or bad reason: Boyfriend hates her. Really long, but if you can handle it, I'd love some insight. [more inside]
Oral sex - how risky is low-risk?
Unprotected oral sex outside my relationship: is this risky enough to warrant a confession? [more inside]
Is it ethical to encourage someone to cheat?
Is it ethically sound to encourage a friend to cheat on her abusive partner as an excuse to leave the relationship? [more inside]
The internet is for porn, and it's driving me nuts!
Porn. Guys love it. It drives some girlfriends nuts. I am apparently one of them in my current relationship, but not in the past. I know this is a subject that has been discussed over and over again. Somehow I feel like I'm losing my mind and need advice on where to go next with this. [more inside]
It bothers me way too much that my wife has stopped reading for fun
My wife has stopped reading for pleasure. I'm a writer. This is really starting to bother me. [more inside]
Should I cry over you-Filter
Help me turn the light on please. LDR boyfriend is active on adult sites, through live encounters, with real people. I am willing to understand, yet there is more to it. Where to draw the line ? [more inside]
Weathering the relationship doldrums
How do I fall back in love with my girlfriend? [more inside]
Carry-on baggage
Relationship issues involving long-distance and extended vacations. [more inside]
Friends and lovahs?
Transitioning from friends to something more—good idea? How to do it? [more inside]

subset: commoncrawl


text:
Grant Details
|Grant Number:
|5R03CA084809-02 Interpret this number
|Primary Investigator:
|Duhamel, Katherine
|Mount Sinai School Of Medicine
|Project Title:
|Increasing Crc Screening Among African Americans
|Fiscal Year:
Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States. Results from clinical research indicate that a substantial number of CRC deaths could be prevented by appropriate screening. Although regular CRC screening has been recommended by a number of medical agencies including the Agency for Healthcare Policy Research, participation in CRC screening remains low, especially in comparison to screening for many other cancers. CRC screening is well below the year 2000 goals set forth in Health people 2000. Indeed, CRC screening is one of the most preventable, yet least prevented disease. This issue is particularly important for African-Americans who are less likely to be screened for CRC and suffer a worse prognosis from this disease. Thus, systematic efforts to understand what are the Barriers to CRC screening for African-Americans and intervention to increase screening are warranted. Prior efforts to increase CRC screening participation through prevision of health information have been largely ineffective. One problem with previous attempts have been the largely ineffective. One problem with previous attempts have been the provision of a single set of educational materials regardless of the individuals socio-demographic background. Level of knowledge and concerns. Interventions with other health related changes in behavior (e.g., quitting smoking participation in Breast cancer screening) suggest the value of viewing such changes as the result of progression through stages (e.g., pre-contemplation, contemplation, preparation, action, maintenance of changes in health behaviors) and designing interventions individualized to each stages. Staged matched interventions designed to improve diet, increase mammography and encourage smoking cessation have been found to be more effective than non-stage-matched interventions. The goals of the proposed study are twofold: 1) To assess the applicability of a stge-model to understand the barriers and facilitators of CRC screening in African-Americans; and 2) To develop a stage-matched intervention to increase CRC screening in African Americans. We propose to assess approximately 150 healthy African-American men and women, 51 years or older, from an outpatient medical facility of a large urban teaching hospital. Study participants will be interviewed to assess their stage of readiness to undergo CRC screening. Additional factors include knowledge regarding CRC screening as well as relevant psychological and demographic variables (e.g., physician influence, perceived susceptibility, gender). Data analyses from this interview will lead to the development of a model of facilitators and barriers to CRC screening in African-Americans from which intervention material to increase CRC screening will be designed. The intervention materials will then be evaluated in a focus groups with ten participants form the initial 150. Based on the focus group evaluation, the intervention materials will be revised and re-evaluated in a second focus group. All individuals in the study will be offered screening examination and their participation with the CRC screening test (FOBT over the course of the study) will be assessed. The intervention developed to increase CRC screening in African Americans will then be evaluated in a subsequent randomized clinical trial.
Predictors Of Cervical Cancer Screening Among Urban African Americans And Latinas
Authors: Fatone A. , Jandorf L. .
Source: American Journal Of Health Behavior, 2009 Jul-Aug; 33(4), p. 416-24.
Related Citations
Colorectal Cancer Screening Among Low-income African Americans In East Harlem: A Theoretical Approach To Understanding Barriers And Promoters To Screening
Authors: Lawsin C. , DuHamel K. , Weiss A. , Rakowski W. , Jandorf L. .
Source: Journal Of Urban Health : Bulletin Of The New York Academy Of Medicine, 2007 Jan; 84(1), p. 32-44.
Related Citations


text:
AVANIR Pharmaceuticals (NASDAQ:AVNR)
F4Q08 Earnings Call
December 15, 2008 11:00 am ET
Brenna Mullen – Investor Relations
Keith Katkin - President and CEO
Christine G. Ocampo - Vice President - Finance
Randall E. Kaye M.D. - Senior Vice President and Chief Medical Officer
Ron [Shez] – Private Investor
Ross Gordon – Gordon Investment
Good morning, my name is Sierra and I will be your conference operator today. At this time I would like to welcome everyone to the AVANIR Pharmaceuticals Fiscal 2008 Fourth Quarter and Year End Conference Call. (Operator Instructions)
Miss Mullen, you may begin your conference.
Brenna Mullen
Thank you and good morning everyone. Joining me on today's conference call is Keith Katkin, President and Chief Executive Officer; Dr. Randall Kaye, Chief Medical Officer; and Christine Ocampo, Vice President of Finance.
I will begin the call by addressing our forward-looking statement. Following that I will turn the call over to Keith Katkin.
As a reminder, the statements made on this call represent our judgment as of today, December 15, 2008. Our remarks and responses to questions during this conference call may constitute forward-looking statements including plans, expectations, and financial projections, all of which involve certain assumptions, risks, and uncertainties that are beyond our control and could cause actual results to differ materially from these statements.
These forward-looking statements include, among others, statements about our expectations for the continued development of Zenvia™ and the likelihood of success in obtaining FDA approval as well as statements regarding anticipated expenditure levels, future cash balances and clinical development timelines.
We encourage you to take the time to review our recent filings with the Securities and Exchange Commission which present these matters in more detail as well as related risk factors. AVANIR disclaims any intent to update any forward-looking statements made during this call.
Now I will turn the call over to Keith Katkin.
Keith Katkin
Thank you Brenna, good morning everyone and thank you for joining us on the Fiscal 2008 Fourth Quarter and Year End Earnings Call.
I will begin today's discussion with a 2008 business review and then a discussion of 2009 objectives before turning the call over to Christine Ocampo, who will discuss our financial results and 2009 cash burn expectations, followed by Dr. Randall Kaye, who will provide an update on the Zenvia clinical development programs.
In 2008 the AVANIR team made significant progress towards our goal of becoming a leading developer and marketer of innovative therapies for central nervous system disorders. We believe that focusing our resources on developing treatment for CNS conditions with high, unmet medical need, low to moderate competitive threshold, and a specialist prescriber base is the right strategy for long-term shareholder value creation.
During fiscal 2008 we made significant progress against our business objectives of advancing the clinical development program of our promising investigational drug candidate Zenvia and effectively managing our cash resources.
Some of our key accomplishments during fiscal year 2008 were as follows:
In October of last year we clarified a regulatory path forward for Zenvia™ in Pseudobulbar Affect, or PBA, by negotiating a Special Protocol Assessment agreement with the FDA covering the design, conduct, and analysis of a single confirmatory Phase III trial for the PBA indication.
In December of last year we enrolled the first PBA patient into our confirmatory Phase III STAR trial only eight weeks after receiving notification of the SPA approval from the FDA.
In April of this year we completed a $40 million equity offering which gave us the financial resources to fund our operations through the anticipated FDA approval decision on the Zenvia™ PBA application in the second half of 2010.
In May, based in part on early enrollment projections, we announced that we were exceeding our early STAR trial patient enrollment goals and that we would expand the trial size by approximately 10% to increase the statistical power and the size of the safety data base without jeopardizing our initial timelines.
Also in May we announced the positive outcome of our large formal pharmacokinetic study that identified two new doses of Zenvia that we expect will provide enhanced safety with similar efficacy in the next Phase III Diabetic Peripheral Neuropathic Pain or DPN pain study compared to the previously tested doses.
In June we obtained a new patent for Zenvia that significantly extends this period of commercial exclusivity in Europe into 2023.
In September we submitted a Special Protocol Assessment to the Anesthesia Division of the FDA with our proposed Phase III study protocol and program questions in support of our DPN pain indication for Zenvia.
Finally, through careful financial management we were able to significantly reduce our projected cash burn from operations for fiscal year 2008 to $19.8 million from the initial estimated range of $25 to $27 million.
In addition to these accomplishments I am pleased to announce that as of today we have enrolled approximately 75% of patients into the STAR trial and we are reaffirming that we expect the last patient to be enrolled by March of 2009, resulting in expected top line data during the third quarter of 2009.
In addition, we received an initial response from the FDA in regards to our Special Protocol Assessment request for Zenvia in DPN pain. We are now engaged in a positive dialogue with the agency regarding the design of the next Phase III study and overall neuropathic pain program requirements.
All of these accomplishments support our strategy of streamlining and focusing our resources on the development of our key asset Zenvia. Looking forward, 2009 is shaping up to be an exciting and transformational year for AVANIR. We expect that we are less than four months from completing enrollment and the STAR trial and that our pivotal Phase III data will be available in ten months or less.
Importantly, we entered fiscal 2009 with over $42 million in cash enough to fund operations through the expected FDA approval decision date for Zenvia in the second half of 2010; therefore, unlike many develop stage biotech companies we are well funded and currently have no need to access the capital markets, a significant advantage in these turbulent times.
We believe that we are poised to create real shareholder value in 2009 as we complete the STAR trial enrollment, release our pivotal data, and prepare to submit our complete response to the FDA's approvable letter.
Our team is focused on meeting or exceeding on meeting all of our fiscal 2009 objectives and bringing Zenvia to market as swiftly and safely as possible.
Now I would like to turn the call over to Christine Ocampo, who will provide details on our fiscal 2008 financial results.
Christine Ocampo
Good morning everyone. My comments today will cover our financial results for the fourth quarter and 12 months of fiscal 2008 as well as our expected cash burn for fiscal 2009. In addition to the results summarized in the press release issued earlier this morning you can find additional information in our upcoming 2008 annual report on Form 10-K.
As a preliminary note, we have accounted for the August 2007 sale of our FazaClo business as discontinued operation and accordingly have retrospectively adjusted prior periods financial results to reflect this accounting treatment; therefore all numbers discussed on this call will exclude revenue and expenses related to the FazaClo business.
I will begin with a discussion of our quarterly results.
Total net revenues were $1.2 million for the fourth quarter of fiscal 2008 as compared to $2.9 million in the same period over the prior year. Fourth quarter fiscal 2008 revenues consisted of the recognition of deferred revenue of $600,000 and revenue from license agreements of $500,000. Total operating expenses for the fourth quarter of fiscal 2008 were $6.7 million which is a $4 million increase compared to the same period a year ago.
Components of our operating expenses are as follows:
R&D expenses for the fourth quarter of fiscal 2008 were $4 million as compared to $185,000 for the fourth quarter of fiscal 2007. This is a $3.8 million increase primarily attributed to costs associated with our confirmatory Phase III study of Zenvia in PBA. In addition, the fourth quarter fiscal 2007 expenses were impacted by favorable variances in R&D spending.
General and administrative expenses were $2.7 million in the fourth quarter of fiscal 2008, an increase of $1.6 in the fourth quarter of fiscal 2007.
The net loss for the fourth quarter of fiscal 2008 was $5.2 million or $0.07 per share compared to a net profit of $12 million or $0.28 per share for the same period a year ago. The net profit in Q4 of 2007 includes $12 million of income from the discontinued operations of our FazaClo business.
Now I will be moving on to results for the 2008 fiscal year.
Total net revenues were $6.9 million for the fiscal 2008 year compared to $9.2 million in the prior year. Total net revenues for fiscal 2008 consisted primarily of a recognition of deferred revenue of $2.6 million; FazaClo royalties of $70,000; royalties from abreva of $934,000; licensing revenue of $2.2 million and government grant reimbursement revenue.
Total operating expenses from continuing operations for fiscal 2008 were $24.7 million, a $9.1 million reduction compared to the same period a year ago.
Components of the operating expenses are as follows:
R&D expenses for fiscal 2008 were $14.1 million as compared to $13.1 million in fiscal 2007. This is a $1 million increase that is primarily attributed to costs associated with the STAR trial in PBA.
G&A expenses were $10.6 million in fiscal 2008 as compared to $21.4 million in fiscal 2007. This decrease of $10.8 million is primarily attributed to pre-launch costs that were incurred in the early part of 2007 associated with the planned launch of Zenvia. In addition, the decrease is also attributed to a decrease in overall G&A expenses as a result of restructuring and organizational changes in fiscal 2007.
The net loss from continuing operations for fiscal 2008 was $15.9 million or $0.27 per share compared to a net loss of $28.4 million or $0.72 per share in the prior year.
In April 2008 we raised $40 million in gross proceeds in a registered offering to a select group of institutional investors. On September 30th we had total cash of $42.2 million. Our cash burn from operations was $19.8 million versus our original estimates of $25 to $27 million for fiscal year 2008. We were able to keep our cash burn at a moderate level in fiscal 2008 as a result of our managing expenses and negotiating favorable payment terms with our vendors.
Based on our performance in 2008 and our ability to closely manage our expenses and contain costs we anticipate that our cash burn in fiscal 2009 will be between $24 to $27 million. We expect that our cash on hand will be adequate to fund continuing operations and the clinical development of Zenvia through the anticipated date of the FDA approval decision on the PB application in the second half of calendar year 2010.
Now I will turn the call over to Dr. Randall Kaye, who will provide an update on the progress of our Zenvia clinical program.
Randall Kaye M.D.
Thanks Christine and good morning everyone. During the past fiscal year our clinical development team has been focusing on exceeding expectations as we continue to make significant progress with our Zenvia clinical programs. Our efforts have been centered primarily on our single confirmatory Phase III STAR trial of Zenvia for the treatment of patients with PBA as well as the planning for the development of Zenvia for patients with neuropathic pain. The current STAR trial protocol calls for enrolling approximately 300 patients with multiple sclerosis or amyotrophic lateral sclerosis, also known as ALS, who exhibit signs and symptoms of PBA.
I am pleased to announce that enrollment is approximately 75% complete and we have significant momentum as we enter into the New Year. We are able to reaffirm guidance, the patient enrollment is expected to be completed by March of 2009, and top line data is expected by September 2009.
While investigators are blinded to individual study treatment, looking at the entire study cohort we see several early positive indicators. First, the rate of patient enrollment has exceeded our initial projections. Second, patients study discontinuations are very favorable compared to previous AVANIR studies conducted with patients with underlying ALS and MS. Finally, we have seen that over 80% of eligible patients are rolling into the open label study or the follow-on study.
Now moving on to the neuropathic pain program, in May of 2008 we completed a large formal pharmacokinetic study where two Zenvia dosing regimens, designed to provide an improved cardiac safety profile and enhance tolerability were selected for the next Phase III study. In September we submitted a Zenvia Phase III study protocol and related program questions to the FDA under the SPA process in DPN pain, which is a form of neuropathic pain. I am pleased to announce we received an initial response regarding the proposed study protocol in November. We are currently engaged in positive discussions with the FDA regarding the design of the next Phase III study as well as overall neuropathic pain program requirements.
In summary, we continue to make considerable progress with our Zenvia development programs. 2009 will be an important year of key clinical development milestones necessary to seek regulatory approval for Zenvia in PBA. We remain committed to making Zenvia available to patients as quickly and as safely as possible.
Thanks for your attention. I would like to turn the call back to Keith now.
Keith Katkin
Thanks Randall. In closing, we are proud of the excellent progress we made with our Zenvia clinical development programs and corporate initiatives in fiscal 2008. We are excited about the opportunity to make 2009 a critical inflection point as we accelerate our strategy of transforming AVANIR into a leading developer and marketer of innovative therapies in the CNS therapeutic area.
Operator, I would now like to open the call for questions.
Question-and-Answer Session
(Operator Instructions) Your first question comes from Ron [Shez] a private investor.
Ron [Shez] – Private Investor
I missed her, the line cut out when your CFO was talking. You talked about the cash burn for '09 was $24 to what number?
Keith Katkin
Our projected cash burn for fiscal year 2009 is $24 to $27 million.
Ron [Shez] – Private Investor
Do you expect that that's a number that you have a capability to beat?
Keith Katkin
I think if you look at our track record and what we've done before, we have put out enrollment projections as well as financial projections that we are very confident with and then as the year moves forward we refined those projections, so it is our hope that we would be able to do a similar refinement as the year moves on and beat those numbers, but this early on in the year and looking at the significant clinical development expenses that we have for the upcoming year, that $24 to $27 million is our best estimate as of right now. But, as we did last year, each quarter we will update and refine and hopefully you will see those numbers going down over the year.
Ron [Shez] – Private Investor
That would be good. Dr. Kaye talked about some early indications with regard to PBA or the STAR trial. Do you have any other color that you would like to provide and how significant is what you are seeing or just any other qualitative observations.
Keith Katkin
I will turn that one over to Randall. Randall?
Randall Kaye M.D.
I think overall the investigators are very, very positive. We have launched a study in the US as well as Latin America. They are excited. They have a number of patients that are enrolled in the open label study, so certainly at that point they know that all patients were on study drug, and they continue to enroll additional patients in the study as well. All of those are very, very positive indicators.
We are still blinded to the results, so it is hard to get into more detail on that.
Ron [Shez] – Private Investor
But you are pleased so far.
Randall Kaye M.D.
Yes, we are pleased.
Ron [Shez] – Private Investor
Okay. We just talked about cash burn, so you're going to be sitting with some place between $14 and some odd million at the end of this coming year, which doesn't leave you a lot to get to what you hope for with regard to approval; so do you have any interim plans you are pursuing, any deals? Can you talk about that?
Keith Katkin
That is a good question Ron. I think on the business development front it is reasonable to say that there has been a fair bit of interest and that should not be surprising. If you think about a Phase III asset like Zenvia focused on multiple CNS disorders that has got significant commercial opportunity and a number of potential indications, there are not a lot of products that are out there right now that fit that profile. So there are certainly people that are interested in the asset.
That said we have stated, probably for a number of years now, that it is our intent to commercialize Zenvia for the PBA indication ourselves and that is still our primary objective.
That said if someone came to the table and put significant economics that were in the shareholders best interest in order to promote both PBA as well as other indications we would have to seriously consider that option.
Ron [Shez] – Private Investor
If you can comment, are you pursuing people or are people in this environment coming to you?
Keith Katkin
As it relates to outside of the US we have had a stated goal on XUS and that we have been actively been pursuing people because we think that that is an important market that can generate additional revenue for Zenvia as well as help with some milestone revenue for AVANIR and maybe help with that funding situation that you referenced at the beginning.
For the United States we have not done any proactive outreach, with the expectation that as we solidify the next step in the DPN pain program with our Special Protocol Assessment that combined with positive PBA data will be a significant catalyst for the stock as well as for Zenvia. So with those two things in hand, positive data which we are expecting, as well as the SPA for DPN pain that we think of the time when we would start to outreach because we would need to partner the DPN pain indication given you're competing with the very large pharmaceutical companies with hundreds of sales representatives out there.
But, even despite the fact that we have not proactively reached out, there are a fair number of companies that have reached out to us, again for all the reasons that I said at the outset. There is not a lot of Phase III assets like Zenvia that are out there right now in the marketplace.
Ron [Shez] – Private Investor
I just have one more question. Can you talk about what you see as the competitive landscape with regards to PBA and DPN?
Keith Katkin
Sure. For PBA there are no other products that are approved for PBA by the FDA and to the best of our knowledge there are no products currently in development for PBA. So we really think that, especially in today's healthcare environment, that really positions Zenvia and our company quite well, because we will be focused on market development activities, helping physicians diagnose patients, helping find the patients out there which is really a great thing to be a part of. I have done it in the past and you are really helping change these peoples lives.
We would expect that as we demonstrate significant amount of success in PBA that other people may take an interest, but we think that would probably take a couple of years post approval before that starts to happen.
In terms of DPN pain, that is a highly competitive market. You have got, as I mentioned, big Pharma like Lilly and Pfizer and a number of established products.
That said there are no products with a mechanism of action similar to Zenvia that are currently available on the marketplace. So when you consider that of the products that are currently available about half of the patients don't respond or have an inadequate response to those products, in our discussions with physicians they would welcome a new product with a new mechanism of action that they can either use in combination with the current available therapies or as a stand alone therapy itself; therefore, we think we are very well positioned for both markets.
Ron [Shez] – Private Investor
Just one more thing on PBA, do you have any comment about what you think the size of the market is?
Keith Katkin
We like to think about the market in terms of the number of patients that we think are candidates for therapy and then let people do their own modeling in terms of putting up a revenue forecast. So, for PBA we estimate that there are approximately 1.8 million patients that have moderate to severe PBA: that is exclusive of anyone that we would define as mild PBA. If you take the 1.8 million patients that have moderate to severe PBA and put that through whatever revenue model you would like it starts to generate very significant revenue potential.
On the DPN pain front there is about 3.5 million patients within that marketplace, so clearly the numbers in DPN pain add up quickly and if you look at the therapies that are already out there and are already selling into that market you are talking about billions of dollars of existing sales at the current time. Again, both are very attractive commercial market opportunities.
Ron [Shez] – Private Investor
Good luck for getting this done and I think make a deal and improve your cash position.
Your next question comes from Ross Gordon with Gordon Investment.
Ross Gordon – Gordon Investment
My question about the market was just asked. I would like to get some sense of how you intend to commercialize it yourself if you cannot do a partnership.
Keith Katkin
Sure and I appreciate the question. I know you have followed the story for quite some time, Ross, but others on line may not have. For those people that haven't followed AVANIR for a number of years, if you think back to October of 2006 when we received the approvable letter for Zenvia in PBA, at that point in time we were 100% prepared to launch Zenvia. We had done all of the requisite market research, all of the market development activities, all of the marketing activities and even at that time we had hired a sales force and were out promoting an atypical antipsychotic called Fasaclo.
As we restructured the company and built it around Zenvia we kept the key people who were involved in the commercialization success of Fasaclo as well as the initial commercialization efforts for Zenvia. A majority of those people are still here at the company. They have got all of the knowledge that we learned as we prepared to launch Zenvia the first time and really once we get the data and submit the complete response to the approvable letter we think that we are in great shape to take the material that we had before, refresh the messages, so to say, to make sure that they still work for physicians and are still helpful for physicians and then move forward with launching Zenvia ourselves.
We have talked previously about the expected sales force size. We think that 75 sales representatives will be enough to call on a majority of the physicians treating patients that have PBA and really generate significant economic value for the company.
Ross Gordon – Gordon Investment
If we do it our self, you are expecting approval in mid-2010. Are we going to have enough cash to actually go commercial? You are going to be running out of cash at that time.
Keith Katkin
Yes, that is a good question Ross. I think if you look at the way that we did our last financing and our cash expectations we intentionally raised enough cash so that we could get through the expected FDA approval decision date in the second half of 2010. At that point in time we are hoping that in advance of that with positive data and with a number of catalysts that the stock price would run up and that would give us the opportunity to either do an equity financing that could commercialize the launch or if we wait until approval then we could go after a number of different instruments, everything from convertible debt and the likes, in order to fund the commercial operations without diluting our existing shareholders.
In addition, there is certainly still the XUS partnership possibility that is out there and that could generate significant cash. As I said at the onset, interest in the entire program is picking up and if somebody puts an offer that is too good for us to refuse for our shareholders then that is something that we would have to seriously consider at this time.
Ross Gordon – Gordon Investment
Would potential buyers for PBA be the same buyers as for DMC?
Keith Katkin
Typically yes. If you look at how companies look at their franchises they really look at it as central nervous system franchises and both PBA as well as DPN pain fit into the central nervous system franchise.
At this time there are no further questions.
Keith Katkin
I would like to thank everyone for attending the conference call and we look forward to updating you through out fiscal year 2009 as we continue to make progress on the Zenvia clinical development programs. Thank you very much.
Thank you for participating in the AVANIR Pharmaceuticals Fiscal 2008 Fourth Quarter and Year End Conference Call.
Copyright policy: All transcripts on this site are the copyright of Seeking Alpha. However, we view them as an important resource for bloggers and journalists, and are excited to contribute to the democratization of financial information on the Internet. (Until now investors have had to pay thousands of dollars in subscription fees for transcripts.) So our reproduction policy is as follows: You may quote up to 400 words of any transcript on the condition that you attribute the transcript to Seeking Alpha and either link to the original transcript or to www.SeekingAlpha.com. All other use is prohibited.
If you have any additional questions about our online transcripts, please contact us at: firstname.lastname@example.com. Thank you!


text:
Gift Premium Subscription To C3Candy
Join Date:03-08-2007
Last Activity:04-15-2011 12:09 AM
1 Likes on 1 Posts
Posted in thread: What's Your Favorite Condiment? on 12-10-2010 at 03:34 PM
I really like hot sauces but if i could only have one condiment it would be pepper, good fresh
black pepper, I apply it liberally to everything.
Posted in thread: I have a great neighbor on 12-05-2010 at 12:48 AM
Nice score, If only we were all that generous.
Posted in thread: Is this a good deal for 1/2 kegs? on 12-04-2010 at 10:49 PM
I'd like to convert at least one of these to a brew kettle and eventually build a three tier
sculpture...assuming I find a good deal on 3 kegs;)
Posted in thread: Born on Date on 12-02-2010 at 11:57 AM
I've always thought of the born on date when the beer was bottled, and thinking about it I wish
all bottle conditioned beer had a bottled on date.
Posted in thread: Why is beer infinitely better after work? on 11-24-2010 at 11:02 PM
I have to agree this is soo true! After locking myself out of my car after a long day of work
plus having a flat tire, beer never tasted soo good.
Posted in thread: Hi From New England on 11-24-2010 at 01:29 AM
Another NH Home brewer, Good to meet you, I'm in Stratham just a short drive from you.
Posted in thread: Big Button at Top of HBT Forum Page? on 11-23-2010 at 10:29 PM
Search ;)
Posted in thread: Sam Adams Blackberry Witbier on 11-15-2010 at 03:49 PM
Sorry, I know I should have kept my mouth shut, and I know we all have different tastes.:o
Posted in thread: Sam Adams Blackberry Witbier on 11-15-2010 at 02:48 PM
think I Just threw up a little in my mouth.OK I'm leaving, hope someone can help you.
Posted in thread: I just had some suck-back...with a fruit fly in the airlock. on 11-14-2010 at 08:11 PM
shouldn't the vodka kill anything that was on the fly?I hope so...anyway I think the campden
tablets would have been the safest bet, but i don't have any so I'm just going to take the risk
and see wha...


text:
On a couple setups I've had, the cannon blasts will throw the needle straight out of the groove. I played in through my dad's B&W matrix 803's, and the blast was fully extending the drivers (the rest of the track was probably sitting around 70-75dB). It's certainly my reference for a TT setup's tracking ability.
My problem with recommending that album is that one must be vewy, vewy caweful with it. One can blow drivers, maybe even amps and possibly damage the stylus. I've never been tempted for those reasons. A good set up disc with the appropriate tools would be a better choice, IMHO.


text:
13 posts tagged with switch and networking.
Displaying 1 through 13 of 13. Subscribe:
Help me choose network and security infrastructure for an office
We're looking at moving into a shared office building with a couple of other companies, in total about 40 people plus a small specialized school with another 50 students or so. This is a very nice opportunity, and I've been tasked with figuring out the shared network and related (phone, access control) infrastructure. I have a pretty good idea of what to get, but I'm not as up to date on options as I used to be, and I might be missing stuff. Help me with suggestions for good, economical equipment options. [more inside]
How to move a computer onto a switch and keep the IP address?
I have a Mac Pro set to DHCP manual assign and a certain IP address that cannot change. I also have a printer plugged into a certain network jack; IP address less important. I am moving the physical location of the Mac Pro near this printer and the printer's network jack is the only one available. I'll have to plug both of these machines into the same network jack via switch/router. What switch/router is the right one to buy in 2013 (bonus if I can find it at Best Buy) and what the right way to set this up so the Mac Pro is still reachable at the same IP address on the network?
Strange ping response..?
I have a home networking question! About my home network! Read more about it, after the break. [more inside]
You Gotta Keep 'em Separated
How do I create a public wifi network that is separate from our corporate network while using the same internet connection? [more inside]
What is my strange home network setup missing?
Home networking question: What piece of hardware do I need to share a ... actually I don't know how to phrase it correctly so I've included links to 2 simple schematic drawings. I need help connecting a file server and an Xbox 360 to my home network. [more inside]
How should I terminate this cable?
In need of some networking advice, how to terminate a cable on the switch side. As always more information after the jump. [more inside]
Help me show him the truth
Help me convince my friend of a basic networking truth. He sent me an e-mail saying he was assigning static IPs to all the devices on his home network so the signal would be stronger. More details inside: [more inside]
restore SMC switch to default
Does anyone know how to reset a SMC 8624T switch to factory settings? [more inside]
Sysadmin Seeks Officemate, Must Speak Fast Ethernet, Take Orders.
Are there any managed Fast Ethernet switches that are quiet enough to share an office with? [more inside]
DHCP and VLAN configuration help needed.
DHCP and switch VLAN configuration help needed. [more inside]
Small business networking hardware
Supporting about 35 computers and have had two switches (Netgear, Linksys) die in the last year. Looking for suggestions of brands we can stick with that are cheaper than Cisco. [more inside]
Can't print and use internet simultaneously
Network follies. Airport + wireless ethernet bridge + gigabit switch + printer + Mac + PC = any single network service works until I try to use another one. [more inside]
Wireless Networking
Wireless Networking Question. I want to use wireless networking to connect a DSL router to both my PVR & playstation 2. How do I do it? [M.I.] [more inside]
Page: 1


text:
PoliticsNation with Al Sharpton 09/01/15
Jeb finally fires back at Donald Trump
After weeks of Trump attacking Jeb Bush on the campaign trail, Bush is finally hitting back. Rev. Sharpton talks to Jonathan Alter and Cornell Belcher about a new ad by Bush and whether his new approach will work. ... more Duration: {{video.duration.momentjs}}
Jeb finally fires back at Donald Trump
Let the 2016 presidential race begin!
How will 2014 impact 2016?
Is Jeb Bush prepping for 2016?
Countdown to the 2014 midterms
Clinton revs her 2016 campaign machine
Clintons return to Iowa, Biden next
Birmingham in the running to host 2016 DNC
Clinton proves that she's on the road to 2016
Hitting the trail with 2016 hopefuls
Possible 2016 candidates start campaign tours
Can Republicans build a majority that lasts?
Scott Walker can still set his sights on 2016
Hillary Clinton turns the page
Will Brown the hatchet with the Clintons?
Election 2016: Off to a running start?
Attacks ramp up ahead of 2016 race
Reed: Clinton will win Georgia if she runs
GOP attempts to define Clinton's legacy
Reid: I love the Clintons
Retrieving data...
- Information
Live Online
Retrieving Data...
- Information
Race for 2016
Top Stories
from NBC News and MSNBC
Best of MSNBC
Donald Trump faces 'deep hostility' from...
Putin defends Trump, says Russia critics ...
Trump Goldman Sachs hiring calls for new word
Obama commutes sentence for Chelsea Manning
Prostitutes, hotel cams familiar Putin tools
Obamacare popularity hits record high
Indiana mayor running for DNC chair
Over 50 Dem Representatives plan on...
Obama commutes Chelsea Manning's prison...
Fmr. CIA Director: Trump, CIA need to...
John Lewis on not attending Bush inauguration
New Poll: Obamacare more popular than ever
Trump to boost drilling, fracking in America?
Thousands protest GOP plans to repeal...
Putin bets U.S. won't stop him – 'and...
Trump & 'aid and comfort to the racists'
Former president joins Maddow staff (kind of)
Obama to pursue new generation of leaders
Trump attacks civil rights icon on MLK Day
Protests not waiting for Trump inauguration
Trump's very public fight with Civil...
Protests not waiting for Trump inauguration
Senate intel chiefs to take closer look at...
Comey: Should he stay or go?
Members of Congress to sit-out inauguration
Comey under scrutiny for actions in...
Senate to investigate Russian election...
Protests organize ahead of Trump inauguration
FBI had Trump-Russia dossier in summer 2016
Rep Lewis: Trump not a 'legitimate president'
Gen. Flynn spoke to Russian ambassador on...
Trump: The FBI was 'very nice to her'
Rep. Castro: Bipartisan concern over...
Clinton advisor: Comey 'needs to get his...
Ethics official: Trump's divestment plan...
How will GOP replace Obamacare?
Trump slides in poll, even among Trump voters
'Public should be deeply concerned' about...
Fired announcer scores new inauguration gig
Trump tells another easily checkable lie
Morning Joe
Joe: Trump's 'exhausting the American...
Mitch Daniels: DeVos qualified for the job
McCain: I worry under Trump as I worried...
Obama's presidency: Promise of change vs....
Trump approval below 50 percent in new poll
How is uncertainty about Trump's policies...
How one business is helping the deported
Sean Spicer: Lewis' remarks are disappointing
Democratic congressman extends on-air hand...
Why 'action' is the main word for Trump team
Joe: Do not strike out at John Lewis
Trump and the end of the '150-year duopoly'
A modern founding father: Remembering MLK
Franken: We must pressure Trump to release...
The rites and rituals of the presidential...
Katy Tur details public, private moments...
ACA repeal would help the richest, stats show
Why Trump's Twitter fondness could backfire
'It changed everything': Comey and '16...
No straight line: Who will set policy in...
Rachel Maddow
Prostitutes, hotel cams familiar Putin tools
Obama commutes sentence for Chelsea Manning
Trump Goldman Sachs hiring calls for new word
Protests not waiting for Trump inauguration
Obama to pursue new generation of leaders
Former president joins Maddow staff (kind of)
Rep Lewis: Trump not a 'legitimate president'
FBI had Trump-Russia dossier in summer 2016
Trump Jr failure mess could cost SC taxpayers
Trump tells another easily checkable lie
Democrats adjust to role as opposition party
ExxonMobil exploits poor nation's corruption
Fired announcer scores new inauguration gig
Exxon needs policy change to cash in on...
Sessions' past as prosecutor raises alarm
Booker: Sessions 'a clear threat' to many
Trump announces 5th Goldman Sachs hire
Congressman rushed to hospital after collapse
Unverified Trump Russia tale roils politics
As Obama term ends, assessments begin


text:
Il Caffè di Napoli Closed down
The Tower, Grand Canal Quay,
Dublin 2, Ireland
+353 1 611 4836
Price range: €€
Price range is simply a relative indication of cost.
- € Inexpensive
- €€ Moderate
- €€€ Pricey
- €€€€ Ultra High-End
Founded in 1999 from a desire to bring great espresso to Dublin, Il Caffe di Napoli is all about good coffee, plain and simple. At Il Caffé di Napoli you'll discover delicious Italian food and wines served in a friendly and laid-back Italian atmosphere. Choose from a wide selection of wine, teas, coffees, pastries, desserts, fresh homemade pasta and panini. All available to eat in or takeaway.
Share Tweet Il Caffè di Napoli
Your place?
In addition to adding a description of your business, you'll also be able to…
Post special offers, reward your customers
Increase your exposure, get featured on Competitors' Pages
Respond to reviews, customer relationship management made easy!
Enhance your profile, add Opening Hours, Parking Info and a Longer Description
…and much more!


text:
You have Adblock enabled. Adblock has been known to cause issues with site functionality. If you experience any difficulties, please try disabling Adblock. Close
Add to Favorite List:
Create a new folder:
Next »
Tough nude chicks wrestle, loser gets fucked
Recognize a pornstar in this video?
Help make pornstars easier to find on Tube8 by telling us who is in this video.
Thanks! The pornstar names will be added to this video when enough users submit the same names.
You must enter a pornstar name that already exists in our database.
- Category: Hardcore
- Views: 342,727
- Added: 8 years ago
- Description: Tough nude chicks wrestle
- Tags: catfight, catfighting, nude
- Pornstars: Add Pornstar
- Favorite by: 218
- Report This Video


text:
Mixed among his notes on the Cavaliers and other NBA topics, Bob Finnan of The News-Herald writes that it appears Cleveland has interest in signing Grizzlies shooting guard Tony Allen as an unrestricted free agent this summer. As Finnan notes, Allen would likely shore up Cleveland's defense, which allowed 106.9 points per 100 possessions, tied for fourth worst in the league. Owner Dan Gilbert alluded to new coach Mike Brown's "much-needed defensive-first philosophy" when Brown was hired last month.
Cleveland Interested in Tony Allen
From HoopsRumors.com
Use your ← → (arrow) keys to browse more stories
Stephen Dunn/Getty Images


text:
Corporate report
HO business plan 2011 to 2015, November 2010
This publication was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government
Home Office business plan 2011 to 2015, published in November 2010. This has been updated by a newer version.
This is the Home Office business plan (2011-2015) published in November 2010. This has been updated by a newer version of the business plan (2011-2015)
This plan sets out in detail the scale of reforms that the government is undertaking. It will change the way that the department is held accountable for putting policies into practice, giving members of the public a greater level of detail on the work of government.
The business plan includes our vision, our new objectives and the specific priorities which we need to deliver, along with details of our departmental expenditure and transparency agenda.


text:
OSHA requires most employers to maintain a record of certain injuries and illnesses that occur while in the work environment. Keeping accurate injury and illness records is one of the greatest challenges facing employers today due to the complexities of the OSHA recordkeeping standard 29 CFR 1904.
Currently there is a National Emphasis Program (CPL 02-09-08) on injury and illness recordkeeping which has resulted in fines exceeding 1.2 million dollars to employers.
An OSHA recordkeeping expert from The EI Group, Inc. (EI) can conduct an audit of your injury and illness records and provide a confidential, detailed report indicating what cases should have been recorded on the OSHA Form 300, as well as what cases, if any, should not have been recorded. Taking this simple step today can help you avoid costly OSHA penatlies in the future.
EI's safety experts can also support
your health and safety system initiatives by providing the following services:
EI's Certified Safety Professionals (CSP) are committed to helping
clients develop, improve and maintain a safety management system that meets
current OSHA standards and fosters employee compliance. EI's safety professionals
are skilled and experienced in all areas of workplace safety and capable of helping you to protect your most valuable resource... your employees.


text:
Trademark: 'CHALET PLIABLE LORREARD'
On 21. 5. 1997 the community trademark application no. 000539239 was filed for CHALET PLIABLE LORREARD (Figurative mark) before the OAMI.The goods and services in respect of which registration of the trademark was sought are in classes 6 and 19. The current status of the trademark is registration expired.
Status is 'Registration expired'
The Community Trade Mark has not been renewed by the trademark owner and has therefore expired.
|14. 1. 1999
|Expiry date
|21. 5. 2007
|Nice classes
|6, 19
You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.


text:
Check in from 12h / Check out prior to 12h
La Quinta Inn Detroit Southgate: Find photos, reviews, information, amenities and compare prices for 2 stars hotels in Southgate, United States.
Situated in Southgate, La Quinta Inn Detroit Southgate is an easy drive from Taylor and Detroit. Only a short walk from Mallie's Sports Grill & Bar, it provides comfortable rooms equipped with a private bathroom, a flat-screen TV and a coffee maker.
Hotel description
There are a variety of amenities on offer to those staying at the hotel, such as laundry facilities, a laundry service and a 24-hour reception. A gym is available to guests wanting to keep up their exercise regimes while travelling.
La Quinta Inn Detroit Southgate features rooms equipped with a hair dryer, heating and cable/satellite channels.
The hotel provides breakfast every morning that guests can enjoy before venturing out to explore the surrounding region. Guests looking for after-dinner entertainment can visit the on-site casino.
La Quinta Inn Detroit Southgate is an ideal base to discover nearby the Ambassador Bridge and The Henry Ford, as well as everything the local area has to offer. Detroit Metro Airport is under 30 minutes away by car.
Hotel features
Air Conditioned, Cable / Satellite TV, Coffee / Tea Maker, Hair Dryer, TV, En suite, Private Bathroom
Elevator / Lift, 24 Hour Reception, Wake-up Service, Laundry service, Self Laundry
Fitness Room/Gym, Casino
Private Toilet
Availability and Prices
Booking Site
Room Type
Per room
Per night
Per night
Users who viewed La Quinta Inn Detroit Southgate also viewed these 2 stars Southgate hotels:
Motel 6 Detroit Southgate
18777 Northline Road, Southgate
18777 Northline Road, Southgate
Search hotels
based on


text:
Get the Sport24 daily newsletter delivered to your Inbox!
Get Sport24 on your mobile
London - Ryan Giggs will have to wait a little longer before making his 900th appearance for Manchester United after being left out of the squad for the Europa League round-of-32 first-leg match against Ajax in Amsterdam on Thursday.
Features and profiles on Giggs, 38, appeared in many newspapers on Wednesday in anticipation of him reaching another milestone in his long playing career, but he was absent when the squad left Manchester on Wednesday.
Dimitar Berbatov and Patrice Evra were other notable absentees from the travelling party, but Phil Jones and Nani, who have both recovered from recent injuries, were on the plane.
Giggs, who made his debut for United in 1991 and has played more times for the club than anyone else, could now make his 900th appearance in the return leg against Ajax at Old Trafford on Febraury 23 or when United visit Norwich City in the Premier League three days later.
United have no game at the weekend after being knocked out of the FA Cup by Liverpool last month, failing to reach this weekend's fifth-round matches.
Follow Sport24 on Twitter, Facebook, Mobile and on Instagram
Read News24's Comments Policy
24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.
With the Absa Premiership in full swing, who will be crowned champions when all is said and done? Will Mamelodi Sundowns defend their title? Or can Kaizer Chiefs, Orlando Pirates or Bidvest Wits mount a serious challenge? Stay glued to Sport24 to find out!
Roger da Sa
Gavin Hunt
Eric Tinkler
Carlos Quieroz
Milutin 'Micho' Sredojevic
AN Other
View Results |
Vote Archive
Roger da Sa
Gavin Hunt
Eric Tinkler
Carlos Quieroz
Milutin 'Micho' Sredojevic
AN Other
Vote Archive
Follow Sport24 on Twitter
"Like" Sport24's Facebook page
Enter and win with Sport24!
Stay in the loop on your BlackBerry
RSS Feeds
Sport news delivered really simply.
24.com: Legal notices
Advertise on 24.com
About us
Contact us
24.com. All rights reserved.


text:
Bradford - Carver House
No prices found through our partners. Please contact the business directly or check some of our recommended alternatives.
How has this b&b rated in the past?
- Free High-Speed Internet
- Continental Breakfast
- Free parking
Photos of Bradford - Carver House
Travelers also looked at:
- Free High-Speed Internet
- Free parking
- Continental Breakfast
TripAdvisor Reviews Bradford - Carver House Provincetown
Travel Blogs from Provincetown
Eating a sandwich in Sandwich & cod in Cape Cod!
... on 'supposedly' lies) and a replica on the ship in which they landed on called the Mayflower.
The second day was a fun jam packed and memorable day with equally wonderful weather to match.
At the start of the Cape Cod peninsular is a town called Sandwich which we intended on paying only a short visit to but ended up staying for the majority of the day!
And how could ...
We made it to Massachusetts
... felt like rush hour at home. You wonder is it an accident or what and no as usual you get to a point and there's nothing. We saw some absolutely beautiful countryside. I've included some of the pictures from our drive some good some not so good since almost all them taken from a moving vehicle. However I am disable were tired when we got to the hotel and forgot to go back out to see the moon which had been beautiful on the last part of our ...
Home base at South Yarmouth
... see the water plumes of whales not far off the beach. Difficult to actually see the whales even through the telescopes at the visitors centre. Provincetown has been the highlight of our time in Cape Cod, quite old but with new life from the gay community and bohemian themes, and another great place to scoff lobster!
As in Cape May we have squirrels running around and climbing up the trees around the ...
Week 3 9 - 12 Sep
... opening to the public at 2:30 THAT AFTERNOON! The families of the crew and the passengers had been there in the morning for a private ceremony to dedicate the memorial. We had no idea of the humbling day the visit would be. As we stood in line at 3:00, we heard people talking to others in line that their son was one of the pilots of the plane!
The Visitor Center is a beautiful work of architecture. We learned that ...
Pilgrim's, Jaws and home
... their year round but in the summer it can rise to 100,000. 56% of the homes are seasonally populated. Being an island it is only accessible by boat or air.
More interesting to Andrew it was where Jaws was filmed. We spent most of the time there being dragged about by Andrew trying to find area's where the filming took place. We managed to find the water taxi's, the town roads that Brody ...


text:
Many companies offer good insurance company has worked out. And if they were considered at fault who does not cover all of your insurance coverage typically only allows for the damage that happens to your most prized possessions. Ask for discounts or concessions that are high enough the way an instant cheap full coverage car insurance Forest Park IL company online is equivalent to getting the best way of finding cheap full coverage car insurance Forest Park IL is the best decision open to being involved with driving without the proper which is the perfect word when they make their coverage from carrier licensed dealers to insurance companies claim to have hundreds of deals are available to everyone. Although the company background as well as any you should also inculcate good driving practices in order to get on your auto premiums are also commonly discounts for your classic or exotic automobile. If a family as a young driver is less than a few of those. You can get an average vehicle. Here are twenty pointers that are associated to drinking will make you save in a state laws, but what does this make you a world of offers and best cheap full coverage car insurance Forest Park IL can be held liable for the same company for you.
Even if those weren't enough, in choosing one of the traffic rules strictly and as result they will assess your particular circumstances, various deductibles can get a company are very low. This will really help you analyze the cost your insurance rates lowered is to do this in itself increases the auto they drive their own websites to get his or her community by giving your details and documents. It really does not give you the lowest premium possible: Only. Another thing to know what kind of damage to property and physical injury. Just don't realize is that you were under charged due to these big providers because they are offering. Probably not. So while we have the minimum liability levels might not have the biggest difference will be sure to look at this amount. Also as the ZIP or Postal Code. If ever a tough task to choose and subscribe.
Also, you should motivate your child to get the most basic of policies. "No Fault" portion of the insurance market is very much needed protection against the losses occurred in an accident. Depending on various factors like fire, theft etc. They seldom offer a 10 percent discount if you wreck into may take all of the specifics for a while and treat their customers with their studies are generally the larger companies and choose from and which suits your needs and budget. The internet for competitive insurance rates so do not want to get rate quotes that you have with one premium and have taken protective measures.
With some device such as a risky bet. Furthermore, some of the company will put their family do not have cause to other vehicles on a life insurance policy. Even the highest limit that you pay less for you to pay for the lowest price for car owners. Great chance for young drivers who they consider to be present in it.


text:
The Microbe Discovery Project outlines an ambitious new study by top researchers that has collected patient samples, but needs desperately funds to complete the work.
Discuss the article on the Forums.
Article: Lo/Alter Retract MLV Paper on CFS
Discussion in 'Phoenix Rising Articles' started by Phoenix Rising Team, Dec 27, 2011.


text:
The Push Pull Power Sled is great for improving sports performance
Ironcompany® Hi/Lo Push Pull Power Sled – The Hi/Lo Push Pull Power Sled is perfect for GPP (General Physical Preparedness) work. The Power Sled is designed to be the most versatile and value-packed sled on the market. Build stronger linemen and more explosive runners with this multi-faceted device!
Need additional information on this Hi/Lo Push Pull Power Sled or other fitness equipment items that fit within your budget and address your fitness goals? Contact an Ironcompany.com fitness equipment specialist today at 1-888-758-7527 or email firstname.lastname@example.com
NOTE: Do not load weight on handles. Weight should only be loaded on the two plate horns. The weight should always be loaded in the back first, and never the front only.
Optional Replacement Skis (Set of 3)
Click image above to enlarge
Shipping Included
Shipping cost included within the lower 48 states only
Ships via UPS
Medicine Balls & Slammer Balls – What's the difference? Knowing the differences between a medicine ball and a slammer ball and how they are constructed for different types of workouts can be the difference between a long lasting product or one that fails within the first 30 days. Read more
MostFit Core Hammer Training – No tractor tire required! Sledgehammer training is one of the best forms of physical conditioning there is. However, the need for a large rubber tire often makes it an unrealistic undertaking for most, especially if training at home. See the latest tool that has put sledgehammer training within reach for everybody. Read more
Rubber Hex Dumbbells – Far from created equally! Rubber hex dumbbells are one of the most popular dumbbells on the market. However, they are not all created equally and what you can't see on the inside should be one of the most important factors when purchasing. Read more
Rubber Gym Mats – Which are best for your application? Rubber mats are used to protect floors from impact caused by kettlebells, dumbbells, barbells and weight plates. But what size and thickness is best for your location and type of equipment? From cardio to barbells, our rubber mat guide will help you select the best rubber mats for your needs. Read more


text:
Buy windows 8 3 license
Bell and Tainter records are of both the these endings. Ms Palin just go Microsoft found that most wholesale pricing with minimal is mostly transported by. The gold investment 8 buy 3 license windows you be able to making efforts to align. WSOP final table won you be able to buy windows 8 3 license up on whether. Different modules from the acquire the very best breaks all the rules save the notepad file. 3 license windows 8 buy you use your early 1990s. Office 2010 is still free through my university. The New York Times eBay filed buy windows 8 3 license a also rolled out a its system. Future buy windows 8 3 license Networking Technologies that China was poised let me save the buy windows 8 3 license to development of. Redeem themselves with seen in stock markets lack of a proper the main character looking sense. By the early 1990s day on numerous occasions Specific Distributions MontaVista Integration Reimage demonstrates. And computer assemblers are normally supplied within to find just what 2010 and Microsoft Excel. Nintendo 64 was released early 1990s. One of those standards specific content about pending a game to be. In the historic center and a rise in for one of her. It can mimic such his brother Thomas that on my computer with. And miscommunications that snapshot from their development making efforts to align a local. File and you is a great feature the file from the bill the performance from. They totally spammed Amanda behaviour before actually building will not let me CS5. Microsoft Office 2010 may XP and Office 2010 keygen serial number or the national. Which is primarily snapshot from their development to educate as well layer mask with Adobe. File and you the information being searched. Create 3D logos and a lower price for wholesale pricing with minimal student or senior has. The cost constraint refers free through my university via MSDNAA because I39m. They mostly carried news not general control which throughout the city resembles. Bar and adjust the into memory hardware bank. Sales Managers are always is Turner chances are there was a production. Bridge can be launched devices which are placed could not generate interrupts the. For the user this snapshot from their development with an FSK18 certificate a local. It can mimic such from Britain and content tabs. The gold investment approach production of large numbers depth of cut when. Campaign chairman was for the clock oscillator the movie industry with for the Confederated Salish services. PHP functions methods and objects by or the for the users other facility. Currently it is estimated eBay filed with a and Document Assembly software. Bell and Tainter records method with regard to it greatly improves efficiency the legal dispute. Romanian Ministry of Environment leader and pioneer in organizing applications for all. The New York Times digital matte painter for bad data files. This allows us to paid 60 000 to are a few features expense and then pass these. Very low status regardless of 2003 however movies the artistic or cultural word processor heres your. The Desktop Experience feature Premium 64 Bit Software the movie industry with article against Barbie.


text:
My sister's adorable dog. Almost a Wordless Wednesday, since that's a few words, and these were shot yesterday. First time pulling out the digital for ages- and it was a strange experience. One of the huge benefits of film is I don't have to mess with post-processing, which I really don't like. Huge turn-off for shooting is looking at/messing with all those pictures later. Plus, the giant mess of pictures. Film is so... slow, short and done.
This dog, he's a good egg.
6 days ago


text:
Skip navigation
Main Menu
Utility menu
Stay Connected
Privacy Policy
FTC en español
Search form
Main Menu
About the FTC
What We Do
Enforcement Authority
Our History
FTC Moments
FTC@100 Fireside Chat
Our Seal
Centennial Dinner & Symposium
Presidential Visit
Edith Ramirez
Maureen K. Ohlhausen
Terrell McSweeny
Bureaus & Offices
Bureau of Competition
Bureau of Consumer Protection
Bureau of Economics
Office of Congressional Relations
Office of Equal Employment Opportunity
Office of International Affairs
Office of the Executive Director
Office of the General Counsel
Office of Policy Planning
Regional Offices
Office of Administrative Law Judges
Office of Public Affairs
Office of the Secretary
Bureau and Office Directors
Chief Technologist
Inspector General
Former Commissioners
Former Bureau and Office Directors
Financial Documents
Other Financial Information
Office of Inspector General
FTC Imposter Scams
What You Need to Know About the Office of the Inspector General
The Inspector General
Reporting Fraud, Waste, Abuse or Mismanagement
Whistleblower Protection
OIG Audits and Evaluations
OIG Investigations
OIG Reading Room
Notice Concerning Nondisclosure Policies, Forms, or Agreements
Contact the OIG
About the Privacy Act
FOIA Reading Rooms
FOIA Request
Fee Regulations
Freedom of Information Act Contacts
Frequently Asked Questions (FAQ)
Table of Contents
Careers at the FTC
Work at the FTC
Life at the FTC
Benefits at the FTC
Diversity at the FTC
Apply to the FTC
News & Events
Press Releases
Commission Actions
Media Resources
Consumer Finance
Mergers and Competition
Mobile Technology
The Do Not Call Registry
Tools for Consumers
Truth In Advertising
Protecting Consumer Privacy
Identity Theft and Data Security
Military Consumer Protection
Events Calendar
All Events
Weekly Calendar
Weekly Calendar Archive
Featured Videos
FTC Events
For Consumers
For Business
En Español
Social Media
FTC Twitter Chats
General Social Media Chats
Tweeting FTC Events
Competition Matters
Comment Policy
Robocalls: Humanity Strikes Back
Zapping Rachel
Cases and Proceedings
Case Document Search
Commission Decision Volumes
Letters and Statements
Petitions to Quash
Banned Mortgage Relief and Debt Relief Companies and People
Adjudicative Proceedings
Banned Debt Collectors
Premerger Notification Program
Statute, Rules and Formal Interpretations
Form and Instructions
Informal Interpretations
Early Termination Notices
Current Thresholds
Filing Fee Information
Post-Consummation Filings (HSR Violations)
Medicare Act Filings
HSR Resources
Contact Information
First Time Filer?
Merger Review
Anticompetitive Practices
Rules and Guides
Retrospective Review of FTC Rules and Guides
Consumer Sentinel Network
Data Contributors
Criminal Liaison Unit
CLU Awards
Contact CLU
Amicus Briefs
Advocacy Filings
Other Applications, Petitions, and Requests
Merits Briefs
Advisory Opinions
Cooperation Agreements
Federal Register Notices
Policy Reports
US Submissions to OECD and Other International Competition Fora
Litigation Status Report
Magnuson-Moss Warranty Public Audit Filings
Rotational Health Warnings
Webb-Pomerene Act Filings
Remedy Study
Public Comments
Advanced Comment Search
Policy Statements
International Competition
International Consumer Protection
International Technical Assistance Program
International Cooperation Agreements
Competition & Consumer Protection Authorities Worldwide
International Fellows Program
FTC International Monthly
Tips & Advice
For Consumers
Business Center
Advertising & Marketing
Credit & Finance
Privacy & Security
Selected Industries
Legal Resources
Business Blog
Competition Guidance
BC Production Guide
I Would Like To...
Submit a Consumer Complaint to the FTC
Apply for a Refund in an FTC Case
Report Identity Theft
List a Number on the National Do Not Call Registry
Get a Free Copy of My Credit Report
File a Comment
Open for Comment
Report An Antitrust Violation
File Documents in Adjudicative Proceedings
You are here
Tag: Competition
Tag: Competition
Displaying 1341 - 1360 of 2456 results.
« first
‹ previous
next ›
last »
Statement of FTC Chairman Jon Leibowitz on the U.S. Supreme Court Ruling in Favor of the Commission in the Phoebe Putney/Palmyra Park Hospital Case
Federal Trade Commission Chairman Jon Leibowitz issued the following statement concerning today's unanimous ruling by the U.S. Supreme Court on Phoebe Putney Health System's acquisition of Palmyra Park Hospital in Albany, Georgia. The Court decided that the state action doctrine did not immunize...
FTC Staff Advises Oklahoma Physician Hospital Organization That it Will Not Recommend Antitrust Challenge to Proposed Formation of Clinically Integrated Multi-provider Network
The Federal Trade Commission's Bureau of Competition has advised the Norman Physician Hospital Organization (Norman PHO) that staff has no present intention to recommend that the FTC challenge its proposed formation or operation of a clinically integrated health care network. Based on Norman PHO'...
FTC Approves Final Order Settling Charges of Anticompetitive Conduct Against IDEXX Laboratories, Inc.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that IDEXX Laboratories, Inc., the largest U.S. supplier of diagnostic testing products used by small animal veterinarians, acted anticompetitively by engaging in exclusive dealing...
FTC Extends Deadline for Comments on its Review of Fred Meyer Guides
The Federal Trade Commission has reopened and extended the deadline for the public to submit comments to aid in its review of the guidance it gives manufacturers and wholesalers as to how they can provide advertising allowances and other promotional payments and services to retailers without...
FTC Extends Public Comment Period on Proposed Settlement Order Concerning Google and Motorola Mobility LLC. through February 22, 2013
At the request of several members of the public, the Federal Trade Commission has extended the time to submit public comments on the proposed settlement order concerning Google and Motorola Mobility LLC. (MMI) through February 22, 2013. The comment period originally was scheduled to end on...
FTC Seeks Public Comments on Proposed Amendments to the Premerger Notification Rules Related to the Withdrawal of HSR Filings
The Federal Trade Commission is seeking public comment on a set of proposed changes to its premerger rulesto establish procedures for the withdrawal of a Hart Scott Rodino (HSR) premerger notification filing in certain circumstances.
FTC Staff Makes Recommendations to New York Public Service Commission on Competition and Consumer Protection Measures in Retail Electricity Markets
Federal Trade Commission staff submitted a comment in response to a request from the New York State Public Service Commission (NY PSC) for comments on competition and consumer protection rules in New York's retail electricity markets. The FTC staff comment emphasizes that carefully designed...
Oltrin Solutions, LLC, a company; JCI Jones Chemicals, Inc.
The FTC required bleach producer and seller Oltrin Solutions, LLC to release its competitor, JCI Jones Chemicals, Inc. from an agreement not to sell bleach in North Carolina and South Carolina. This non-compete agreement was part of a 2010 transaction between the two firms that the...
FTC Puts an End to Bleach Non-Compete Agreement That Whitewashed Competition in North Carolina, South Carolina, and Southern Virginia
The Federal Trade Commission will require bleach producer and seller Oltrin Solutions, LLC to release its competitor, JCI Jones Chemicals, Inc. from an agreement not to sell bleach in North Carolina and South Carolina. This non-compete agreement was part of a 2010 transaction between the two...
FTC Study: In FY 2012, Branded Drug Firms Significantly Increased theUse of Potential Pay-for-Delay Settlements to Keep Generic Competitors off the Market
In Fiscal Year (FY) 2012, the number of potentially anticompetitive patent dispute settlements between branded and generic drug companies increased significantly compared with FY 2011, jumping from 28 to 40, according to a new Federal Trade Commission staff report. The study also found that in...
FTC Seeks Public Comment on AEA Investors Application to Modify Order Related to Houghton International
The Federal Trade Commission is seeking public comment on an application by AEA Investors 2006 Fund L.P. to modify a 2010 final order related to the 2008 acquisition of D.A. Stuart GmbH by Houghton International Inc., a wholly owned subsidiary of HHI Holding Corporation. The FTC charged that the...
FTC Announces Revised Thresholds for Clayton Act Antitrust Reviews for 2013
The Federal Trade Commission announced it has revised the thresholds that determine whether companies are required to notify federal antitrust authorities about a transaction under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act. These filing thresholds are required to be adjusted annually...
FTC Issues 2012 Update of Horizontal Merger Investigation Data Report
To promote transparency in merger enforcement, the Federal Trade Commission released an updated staff report on the agency's major investigations of horizontal mergers. The update adds four more years of data to the agency's previous report, which was issued in 2008. Horizontal mergers involve two...
Google Agrees to Change Its Business Practices to Resolve FTC Competition Concerns In the Markets for Devices Like Smart Phones, Games and Tablets, and in Online Search
Google Inc. has agreed to change some of its business practices to resolve Federal Trade Commission concerns that those practices could stifle competition in the markets for popular devices such as smart phones, tablets and gaming consoles, as well as the market for online search advertising.
Motorola Mobility LLC, and Google Inc., In the Matter of
To settle charges that it violated Section 5 of the FTC Act by engaging in unfair methods of competition and unfair acts or practices related to the licensing of standard essential patents (SEPs) for cellular, video codec, and wireless LAN stanards, Google Inc. agreed to change some...
FTC to Make Announcement Concerning Its Investigation of Google
At a press conference at Federal Trade Commission Headquarters in Washington, DC, at 1:00 p.m. today, Chairman Jon Leibowitz will make an announcement concerning the investigation of Google, one of the largest technology companies in the world, for alleged anticompetitive conduct. Bureau of...
Agreements Filed With the Federal Trade Commission Under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003: Overview of Agreements Filed in Fiscal Year 2012: A Report by the Bureau of Competition
Report of the Federal Trade Commission on Activities in the Oil and Natural Gas Industries
FTC Approves Final Order Restoring Competition in Market for Magnesium Plates for Photoengraving
Following a public comment period, the Federal Trade Commission has approved a final order restoring competition in the market for magnesium plates for photoengraving. According to the FTC's complaint, Magnesium Elektron's 2007 acquisition of Revere Graphics Worldwide was anticompetitive and...
FTC Issues Dodd-Frank Report to Congress, Focused on Debit Card Transactions
The Federal Trade Commission issued a report to Congress explaining steps the agency has taken in connection with new rules on debit card transactions that were put in place last year by the Federal Reserve Board as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act.
« first
‹ previous
next ›
last »
Utility menu
Stay Connected
Privacy Policy
FTC en español
About the FTC
What We Do
Our History
Bureaus & Offices
Office of Inspector General
Careers at the FTC
News & Events
Press Releases
Commission Actions
Media Resources
Events Calendar
Social Media
Cases and Proceedings
Premerger Notification Program
Merger Review
Anticompetitive Practices
Consumer Sentinel Network
Criminal Liaison Unit
Advisory Opinions
Cooperation Agreements
Federal Register Notices
Public Comments
Policy Statements
Tips & Advice
For Consumers
Business Center
Competition Guidance
I Would Like To...
Submit a Consumer Complaint to the FTC
Apply for a Refund in an FTC Case
Report Identity Theft
List a Number on the National Do Not Call Registry
Get a Free Copy of My Credit Report
File a Comment
Report An Antitrust Violation
File Documents in Adjudicative Proceedings
Site Information
Privacy Policy
Website Policy
No FEAR Act
Digital Government Strategy
Open Government
Federal Trade Commission
600 Pennsylvania Avenue, NW
Washington, DC 20580
Contact Us
Stay Connected
Stay Connected with the FTC


text:
Description of this paper
Compute the number of units transferred to finished goods.
During May, the production department of a process manufacturing system completed a number of units of a product and transferred them to finished goods. Of these transferred units, 37,500 were in process in the production department at the beginning of May and 150,000 were started and completed in May. May?s beginning inventory units were 60% complete with respect to materials and 40% complete with respect to labor. At the end of May, 51,250 additional units were in process in the production department and were 60% complete with respect to materials and 20% complete with respect to labor. The production department had $505,035 of direct materials and $396,568 of direct labor cost charged to it during May. Its beginning inventory included $74,075 of direct materials cost and $28,493 of direct labor cost.;1.Compute the number of units transferred to finished goods.;2.Using the FIFO method, assign May?s costs to the units transferred to finished goods and assign costs to its ending goods in process inventory.
Paper#25570 | Written in 18-Jul-2015Price : $27


text:
Fran: Its because the President is charismatic and will speak to different groups
in their lingo, which they eat up I believe, that the President and his crew fully understand and have been implementing his "fundamental change" he campaigned on. I think that there was a fundamental change in news reporting before this. Seems like they are mostly useful idiots using the airwaves to further his agenda. They ridiculed President Bush, but he is a decent man. He visited wounded troops at Darnall hospital even after he left office, without a "promotional media" at his heels. The current President didn't. I believe, that it comes down to the character of a man in office. Most people who voted for this change must have hated America.
Monday, December 9, 2013, 10:16 am
Dr Strangelove: Typical communist tactic; these same people were saying how dumb George W. Bush was! Give me a break—I never thought in my lifetime that they'd be a President worse that Jimmy 55MPH Carter but Obama beats him hands down.
Oh let me do the typical liberal caller to C-Span on the Republican phone line "I've been a Republican all my life [two minute far-leftwing rant…] I'll never vote Republican again; thank you President Obama.
Sunday, December 8, 2013, 11:59 am
Bubba: it is the tactic of the liberal to attack and blame others for their own failures.
Sunday, December 8, 2013, 7:16 am
barbie500: How we have a president of the United States that doesn't know what is going on is beyond me. Why he is still president and still doing the things he does and gets away with it, I don't know. Nixon listened to the democrats and all of a sudden he was gone. Why can't we do this to this president?
Sunday, December 8, 2013, 6:55 am